$PAVM earnings: reduced losses + faster FDA submissions — here’s the historical next-day playbook
How PAVM has reacted before
| Report | Next-day move |
|---|---|
| Aug 2026 | +0.9% |
| May 2026 | +1.2% |
| Mar 2026 | +13.0% |
| Aug 2025 | -0.8% |
| May 2025 | -13.7% |
| Mar 2025 | -5.1% |
Median absolute move 3.1% · higher 3 of 6 · n=6
PAVmed Inc. Common Stock reports reduced losses and accelerated FDA submissions for key devices, enhancing future commercialization prospects.
How $PAVM has reacted to earnings
| Report | Next-day |
|---|---|
| Aug 2026 | +0.9% |
| May 2026 | +1.2% |
| Mar 2026 | +13.0% |
| Aug 2025 | -0.8% |
| May 2025 | -13.7% |
| Mar 2025 | -5.1% |
Base rate (n=6):
- Median absolute next-day move: 3.1%
- Higher next day: 3 of 6
- Biggest up day: +13.0%
- Biggest down day: -13.7%